Improvement Project To Optimizing Nutrition With Higher Protein & Calorie

Clinical Trial Description

This quality improvement project will include a practice change based on national guidelines for the nutritional management of PICU patients. The primary aim of this quality improvement project is to better meet protein needs of ICU critically ill children ;

Study Design

See also
Status	Clinical Trial	Phase
Completed	`NCT03391310` - Use of Honey for Pressure Ulcers in Critically Ill Children	N/A
Completed	`NCT05179564` - Renal Function Assessment in Critically Ill Children	N/A
Recruiting	`NCT03946345` - Iohexol for Measuring Renal Function
Completed	`NCT01260831` - Evaluating Processes of Care & the Outcomes of Children in Hospital (EPOCH)	Phase 2

See also

Status

Clinical Trial

Phase

Completed

NCT03391310 - Use of Honey for Pressure Ulcers in Critically Ill Children

N/A

Completed

NCT05179564 - Renal Function Assessment in Critically Ill Children

N/A

Recruiting

NCT03946345 - Iohexol for Measuring Renal Function

Completed

NCT01260831 - Evaluating Processes of Care & the Outcomes of Children in Hospital (EPOCH)

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03017664
Study type	Observational
Source	Nestlé
Contact
Status	Completed
Phase
Start date	January 15, 2018
Completion date	December 31, 2019

Improvement Project To Optimizing Nutrition With Higher Protein and Calorie Pediatric Tube Feeding

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms